Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Psychopharmacol Bull ; 51(3): 38-49, 2021 06 01.
Article in English | MEDLINE | ID: mdl-34421143

ABSTRACT

Importance: Religiosity and guilt are commonly featured in obsessive-compulsive disorders (OCD). The role of religiosity and guilt in OCD has been frequently studied in the literature and suggested that greater religiosity/spirituality, paranormal beliefs, and magical ideation have often been associated with enhanced obsessive-compulsive behavior. India being a multi-religious country, it is particularly notable that a research was required to assess the role of religiosity and guilt in symptomatology and outcome in OCD, a condition in which religious themes are often present. It has also been documented that the fear of guilt for doing something irresponsibly may lead to OCD symptoms. Objective: The study aimed to seek the role of religiosity and guilt in symptomatology and outcome of OCD. This study also aimed to assess the pattern of symptomatology of patients with OCD and the relation between religiosity and guilt. Settings and Design: This was a single-centered, prospective study for one year with six months follow-up. Methods and Material: Fifty OCD subjects of either gender, aged between 18 years and 45 years were included in this study and were assessed using Yale-Brown Obsessive Compulsive Scale, Belief into Action Scale, and The Guilt Inventory instruments for the measurement of OCD severity, religiosity, and guilt, respectively. All the recorded data were analyzed using IBM® SPSS® version 20.1. Results: At baseline, OCD severity was positively correlated with religiosity and guilt, while after 6-month follow-up, OCD severity was negatively correlated with religiosity and positively correlated with guilt. Conclusion: Religiosity and guilt have significant effect on the symptomatology and outcome of OCD.


Subject(s)
Obsessive-Compulsive Disorder , Adolescent , Guilt , Humans , Magic , Prospective Studies , Religion
2.
Plant Physiol Biochem ; 132: 166-173, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30195856

ABSTRACT

BACKGROUND AND AIMS: Fungicides, though beneficial for agricultural productivity, are known to interfere with the basic metabolism and induce the formation of various biomolecules and also alter the physiological parameters of plant growth. The present study is an attempt to understand the effect of different conc. of benzimidazole (Carbendazim) and dithocarbamate (Mancozeb) fungicides on photosynthetic components such as chlorophyll content, total sugar and phenolic content and various antioxidative enzymes in developing seedlings of chickpea. MATERIAL AND METHODS: Chickpea seeds of two cultivars (PDG-4 and GPF-2) were incubated with different conc. (0.1, 0.25 and 0.5%) of the fungicide for 24 and 48 h and then allowed to germinate for 10 days in an incubated chamber. Seedlings were analyzed for various physiological parameters such as variation in root/shoot length, photosynthetic activity (chlorophyll content), total sugar and phenolic content and activity of antioxidative enzymes such as GPX, CAT and SOD etc. RESULTS AND CONCLUSIONS: Compared to the unstressed samples, fungicide stress resulted in an overall decrease in root/shoot length, relative water content etc. thus indicating that the applied fungicides adversely affects the rate of germination of seedlings. A differential behaviour of various chlorophyll (Chla, Chlb, total chlorophyll) contents suggests that fungicides stress affects the photosynthetic machinery. Estimations of sugar and total phenolic content indicated that higher conc. of the fungicide lowered the total sugar content at the 10-day-old seedling stage; thereby giving an indication that the fungicide may interferes with carbohydrate metabolism. We observed that the level of peroxidase increased at higher conc. of the both types of fungicide as compared to control samples whereas the catalase activity increased in PDG 4 but a lower activity was observed in GPF-2 under increasing conc. of both the fungicides. The levels of superoxide dismutase decreased in PDG-4 but increased in GPF-2 under higher conc. of both the fungicides thus indicating that different varieties of chickpea behaved differently and triggers various antioxidant enzymes as defence mechanism to counter the fungicides stress.


Subject(s)
Antioxidants/metabolism , Benzimidazoles/pharmacology , Cicer/enzymology , Cicer/physiology , Ditiocarb/pharmacology , Fungicides, Industrial/pharmacology , Photosynthesis/drug effects , Sugars/analysis , Carotenoids/metabolism , Catalase/metabolism , Chlorophyll/metabolism , Cicer/drug effects , Glutathione Peroxidase/metabolism , Phenols/analysis , Plant Roots/anatomy & histology , Plant Shoots/anatomy & histology , Superoxide Dismutase/metabolism , Water/metabolism
3.
Pediatr Dermatol ; 32(5): 690-5, 2015.
Article in English | MEDLINE | ID: mdl-26215612

ABSTRACT

BACKGROUND: Beta-blockers have become the treatment of choice for problematic infantile hemangiomas (IHs). Nadolol, a nonselective beta-blocker with potential dosing advantages and a better safety profile than that of other beta-blockers, has been studied as an alternative therapeutic option. Our objective was to characterize the efficacy and safety of oral nadolol in the treatment of proliferating IHs. METHODS: A retrospective cohort study was conducted at the Hospital for Sick Children between February 2010 and April 2012 in patients treated with nadolol for proliferating IHs causing functional impairment or cosmetic disfigurement. The primary outcome was the percentage involution measured independently by two assessors who scored changes in the extent of IHs by comparing serial photographs using a 100-mm visual analogue scale (VAS), on which 5 mm represented 10% change. RESULTS: Forty-four patients treated with nadolol for IHs with adequate photographic documentation were identified. The median age at presentation was 4.5 months (interquartile range 1.5-7.9 mos). There was a mean improvement of 91.8 ± 11.1%. At least 50% improvement was noted in 42 (95%) patients and 75% improvement in 39 (89%) patients. The mean time to 50% and 75% improvement was 2.9 and 3.7 months, respectively. Analysis of variance showed that younger age at the time of treatment start was associated with a higher mean VAS score (% involution) (p < 0.05). Treatment duration (mean 9.5 ± 5.6 months) had no significant effect on VAS score. Test of interobserver correlation showed good agreement (intraclass correlation coefficient = 0.86, p = 0.001). CONCLUSIONS: Oral nadolol is efficacious in patients with problematic IHs. Further large-scale prospective comparative studies are warranted to compare nadolol with other beta-blockers.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Hemangioma/drug therapy , Nadolol/therapeutic use , Skin Neoplasms/drug therapy , Adrenergic beta-Antagonists/administration & dosage , Adrenergic beta-Antagonists/adverse effects , Canada , Child, Preschool , Cohort Studies , Female , Humans , Infant , Male , Nadolol/administration & dosage , Nadolol/adverse effects , Retrospective Studies , Treatment Outcome
4.
JAMA Dermatol ; 149(6): 732-5, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23552442

ABSTRACT

IMPORTANCE: Hidradenitis suppurativa (HS) is a chronic debilitating cutaneous disease for which there is no universally effective treatment. Patients typically present at puberty with tender subcutaneous nodules that can progress to dermal abscess formation. Antiandrogens have been used in the treatment of HS, and studies have primarily focused on adult patients. OBSERVATIONS: We present a case series of 3 pediatric patients with HS who were successfully treated with oral finasteride, resulting in decreased frequency and severity of disease flares with no significant adverse effects. CONCLUSIONS AND RELEVANCE: Finasteride is a therapeutic option that provides benefit for pediatric patients with HS. Further prospective data and randomized controlled studies will provide helpful information in the management of this disease.


Subject(s)
5-alpha Reductase Inhibitors/therapeutic use , Finasteride/therapeutic use , Hidradenitis Suppurativa/drug therapy , 5-alpha Reductase Inhibitors/adverse effects , Administration, Oral , Adolescent , Child , Female , Finasteride/adverse effects , Hidradenitis Suppurativa/pathology , Humans , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...